MAPT and Dravet syndrome: Evidence has shown that three neuron‐derived exosome biomarkers, including Aβ1‐42, p‐tau181, and p‐tau S396, were significantly elevated in the subjects with DS compared to control subjects (p < 0.0001, n = 37 for control participants, and n = 47 for participants with DS).168